Elizabeth Richardson joins Ethics Talk to discuss her article, coauthored Farzana Akkas and Dr Amy B. Cadwallader: “What Should Dietary Supplement Oversight Look Like in the US?”

Dr Alexander Ding joins Ethics Talk to discuss his article, coauthored with Dr Amy B. Cadwallader and other members of the AMA Council on Science and Public Health: “Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?”

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences.

Christopher W. Reynolds joins Ethics Talk to discuss his article, coauthored with Camilo Sánchez Meertens: “How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants?”

During the COVID-19 pandemic, some US federal courts required jurors’ vaccination against COVID-19, which, according to some, made a juror less representative of a peer.

On this episode of Ethics Talk, Dr Ruth Enid Zambrana shows how decisions about demographic data collection have the power to illuminate or obscure health inequity. Then, Drs Fernando De Maio, Diana N. Derige, and Diana Lemos discuss the work that the AMA Center for Health Equity has been doing to advance Latinx health equity.

Dr Amy B. Cadwallader, Joshua J. Klein, and Scott J. Schweikart join this episode of Ethics Talk to discuss safety and limited legal means of reining in social media influencers' advertisements about dietary supplements.

Training, service delivery, and financing are done separately in dentistry and general health care, which has influenced reimbursement structures, access to services, and outcomes.